Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

5 total trials 3 recruiting

Filter these 5 trials by phase, country, sponsor and more.

Open in Search →

A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Lisaftoclax (APG-2575) in Previously Treated Patients with Chro … Recruiting

2023-508005-24-00 5 2024-08-01
A Phase 3 Study Comparing Pirtobrutinib to Ibrutinib in CLL/SLL Recruiting

2023-507699-38-00 5 2022-08-30
Ibrutinib and Obinutuzumab as first-line treatment for patients with Chronic Lymphocytic Leukemia Recruiting

2024-514824-18-00 4 2021-09-16
A Phase 3 Study Comparing Pirtobrutinib (LOXO-305) to Bendamustine plus Rituximab in Untreated Patients with CLL/SLL Recruitment ended

2024-511599-33-00 5 2021-12-22
A Phase 3 Open Label, Randomized Study of LOXO 305 versus Investigator's Choice of Idelalisib plus Rituximab or Bendamustine plus Rituximab … Recruitment ended

2023-507697-40-00 5 2021-07-05

Showing 1–5 of 5 trials